Clinical Rheumatology

, Volume 9, Supplement 1, pp 136–140 | Cite as

Anti-centromere antibodies (ACA)

  • C. G. M. Kallenberg
Article

Conclusion

ACA are directed towards centromeric proteins (CENP) with M.W. of 17 KD (CENP-A), 80 KD (CENP-B) and 140 KD (CENP-C). At least 6 epitopes on these proteins are recognized by ACA, but CENP-B (that has been partially cloned) seems to be the primary autoantigen. ACA are clinically associated with the CREST syndrome or limited cutaneous systemic sclerosis (prevalence ±55%), and are also found in 30% of patients with primary biliary cirrhosis (who demonstrate additionally symptoms of CREST), in a small proportion of patients with proximal scleroderma, but hardly in any other condition. The presence of ACA in patients presenting with Raynaud's phenomenon has strong predictive value for the evolution to limited cutaneous systemic sclerosis including CREST.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Beck, J.S. Variations in the morphological pattern of “autoimmune” nuclear fluorescence. Lancet 1961, i, 1203–1205.Google Scholar
  2. 2.
    Moroi, Y., Peebles, C., Fritzler, M.J., Steigerwald, J., Tan, E.M. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980, 77, 1627–1631.Google Scholar
  3. 3.
    Kallenberg, C.G.M., Van der Meulen, J., Pastoor, G., Snijder, J.A.M., Feltkamp, T.E.W., The, T.H. Human fibroblasts, a convenient nuclear substrate for detection of antinuclear antibodies including anti-centromere antibodies. Scand J Rheumatol 1983, 12, 193–200.Google Scholar
  4. 4.
    Guldner, H.H., Lakomek, H.J., Bautz, F.A. Human anti-centromere sera recognize a 19.5 KD non-histone chromosomal protein from HeLa cells. Clin Exp Immunol 1984, 58, 13–20.Google Scholar
  5. 5.
    Van Venrooij, W.J., Stapel, S.O., Houben, H., Habets, W.J., Kallenberg, C.G.M., Penner, E., van de Putte, L.B. Scl-86, a marker antigen for diffuse scleroderma. J Clin Invest 1985, 75, 1053–1060.Google Scholar
  6. 6.
    Earnshaw, W.C., Rothfield, N.F. Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma. Chromosoma (Berl.) 1985, 91, 313–321.Google Scholar
  7. 7.
    Earnshaw, W.C., Bordwell, B., Marino, C., Rothfield, N. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J Clin Invest 1986, 77, 426–430.Google Scholar
  8. 8.
    Earnshaw, W.C., Sullivan, K.F., Machlin, P.S., Cooke, C.A., Kaiser, D.A., Pollard, Th.D., Rothfield, N.F., Cleveland, D.W. Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen. J Cell Biol 1987, 104, 817–829.Google Scholar
  9. 9.
    Earnshaw, W.C., Machlin, P.S., Bordwell, B.J., Rothfield, N.F., Cleveland, D.W. Analysis of anticentromere autoantibodies using cloned autoantigen CENP-B. Proc Natl Acad Sci USA 1987, 84, 4979–4983.Google Scholar
  10. 10.
    Rothfield, N., Whitaker, D., Bordwell, B., Weiner, E., Senecal, J.L., Earnshaw, W. Detection of anticentromere antibodies using cloned autoantigen CENP-B. Arthritis Rheum 1987, 30, 1416–1419.Google Scholar
  11. 11.
    Tan, E.M., Rodnan, G.P., Garcia, I., Moroi, Y., Fritzler, M.J., Peebles, C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthritis Rheum 1980, 23, 617–625.Google Scholar
  12. 12.
    Fritzler, M.J., Kinsella, T.D., Garbutt, E. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.Google Scholar
  13. 13.
    Shero, J.H., Bordwell, B., Rothfield, N.F., Earnshaw, W.C. Autoantibodies to topoisomerase I are found in sera from scleroderma patients. Science 1986, 231, 737–740.Google Scholar
  14. 14.
    Kallenberg, C.G.M., Pastoor, G.W., Wouda, A.A., The, T.H. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis 1982, 41, 382–387.Google Scholar
  15. 15.
    Catoggio, L.J., Bernstein, R.M., Black, C.M., Hughes, G.R.V., Maddison, P.J. Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis 1983, 42, 23–27.Google Scholar
  16. 16.
    Steen, V.D., Ziegler, G.L., Rodnan, G.P., Medsger, T.A. Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984, 27, 125–131.Google Scholar
  17. 17.
    Tramposch, H.D., Smith, C.D., Senecal, J.L., Rothfield, N. A longterm longitudinal study of anticentromere antibodies. Arthritis Rheum 1984, 27, 121–124.Google Scholar
  18. 18.
    Sarkozi, J., Bookman, A.A.M., Lee, P., Keystone, E.C., Fritzler, M. J. Significance of anticentromere antibody in idiopathic Raynaud's syndrome. Am J Med 1987, 83, 893–898.Google Scholar
  19. 19.
    Weiner, E.S., Earnshaw, W.C., Senecal, J.L., Bordwell, B., Johnson, P., Rothfield, N.F. Clinical association of anticentromere antibodies and anti-bodies to topoisomerase I. Arthritis Rheum 1988, 31, 378–385.Google Scholar
  20. 20.
    LeRoy, E.C. et al. (editorial). Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15, 202–205.Google Scholar
  21. 21.
    Makinen, D., Fritzler, M., Davis, P., Sherlock, S. Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum 1983, 26, 914–917.Google Scholar
  22. 22.
    Kallenberg, C.G.M., Limburg, P.C., The, T.H. Diagnostic and prognostic significance of anticentromere antibodies (ACA). Protides Biol Fluids Ed: Peeters, H., Pergamon Press, Oxford, 1985, 359–360.Google Scholar
  23. 23.
    Powell, F.C., Schroeter, A.L., Dickson, E.R. Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. Q J Med 1987, 237, 75–82.Google Scholar
  24. 24.
    Kallenberg, C.G.M., Wouda, A.A., Hoet, M.H. van Venrooij, W. J. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow-up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988, 47, 634–641.Google Scholar

References

  1. 1.
    van der Woude, F.J., et al. - Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet i 1985, 425–429.Google Scholar
  2. 2.
    Savage, C.O.C., et al.- Prospective study of radio-immunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet i: 1987, 1389–1393.Google Scholar
  3. 3.
    Nagata, N., et al.- Specific sensitization of Lyt-1 + 2- T cells to spleen cells modified by drug d-penicillamine or a stereoisomer. J Immunol 1986, 136, 136–142.Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • C. G. M. Kallenberg
    • 1
  1. 1.Department of Clinical ImmunologyUniversity Hospital GroningenEZ GroningenThe Netherlands

Personalised recommendations